New Products

CHICAGO — MillerCoors on Tuesday announced that a new hard cider, Smith & Forge, will be launched nationally this month. The beverage contains 6% alcohol by volume and features a distinct taste and crisp finish, the company said.

ANAHEIM, Calif. — La Fresh Group, maker of portable Travel Lite and Eco-Beauty wet wipes, has announced the launch of Eco-Beauty Be Good., a line of skin care products made with a natural anti-aging botanical complex of maqui berry, licorice root, ginkgo leaf, grape seed and hickory bark. 



TAMPA BAY, Fla. — The Stephan Co., a developer of hair and skin care products, has created a new line of hair care products designed specifically for Latinas. Enter Imágen.

The Imágen line is comprised of consists of six products:

CINCINNATI — Angry Orchard announced the national release of Angry Orchard Green Apple hard cider. The cider, which will appear on store shelves this week, has the tartness of a green apple and is the first year-round style of Angry Orchard hard cider made with American apples, the company said.

EWING, N.J. — Church & Dwight on Tuesday announced that the Food and Drug Administration has cleared the First Response Gold Digital Pregnancy Test to determine if a woman is pregnant up to six days before her missed period and with more than 99% accuracy from the day of her expected period. In addition, the First Response Early Result Pregnancy Test, which was previously cleared to determine if a woman is pregnant up to six days before her missed period, also has been FDA-cleared to detect pregnancy with more than 99% accuracy from the day of her expected period. 

EMERYVILLE, Calif. — Clif Bar & Co. on Monday introduced its latest line of snack bars — Clif Mojo Fruit & Nut and Clif Mojo Dark Chocolate. Crafted with 70% organic ingredients, Clif Mojo Fruit & Nut and Clif Mojo Dark Chocolate deliver a convenient and gluten-free snack that supports today’s on-the-go lifestyle, Clif Bar noted. 

JERUSALEM — Teva Pharmaceutical Industries on Tuesday announced that it received approval for generic Evista (raloxifene) tablets, 60-mg, in the United States. The company was the first to file, which means the product is eligible for 180 days of marketing exclusivity. Teva will begin shipping the drug within the next 30 days.

Evista 60-mg tablets, marketed by Eli Lilly and Co., had annual sales in the United States of approximately $824 million as of December 2013, according to IMS data. The drug is used to prevent and treat osteoporosis in postmenopausal women.

READING, Mass. — Physicians Interactive, a provider of online and mobile clinical resources and solutions for healthcare professionals, and McKesson Patient Relationship Solutions, a provider of pharmaceutical manufacturer-sponsored patient adherence programs, on Tuesday announced a collaboration to jointly deliver Coupons on Demand. The new solution is designed to provide clinicians convenient access to medication cost-savings offers and adherence support through a patented web-based platform.